Acceleron Pharma reported $58.66M in Operating Expenses for its second fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Acceleron Pharma XLRN:US $ 58.66M 2.75M
Akebia Therapeutics AKBA:US $ 118.08M 145.88M
Alexion Pharmaceuticals ALXN:US $ 2814.8M 2065.5M
Amgen AMGN:US $ 388.3M 7.7M
Bayer BAYN:GR 2.08B 1.05B
Biomarin Pharmaceutical BMRN:US $ 47.04M 7.33M
Bluebird Bio BLUE:US $ 22.48M 45.3K
Clovis Oncology CLVS:US $ 125.81M 6.56M
Dicerna Pharmaceuticals DRNA:US $ 71.77M 2.17M
Eli Lilly And LLY:US $ 4302.6M 33.6M
Exelixis EXEL:US $ 183.94M 9.84M
Gilead Sciences GILD:US $ 8126M 4980M
GlaxoSmithKline GSK:LN 477.4M 230.2M
Johnson & Johnson JNJ:US $ 16.68B 2.28B
Neurocrine Biosciences NBIX:US $ 225.8M 47.6M
Novartis NOVN:VX 9.27B 694M
Pfizer PFE:US $ 8360M 920M
Ptc Therapeutics PTCT:US $ 26.25M 10.13M
Puma Biotechnology PBYI:US $ 63.55M 2.02M
Regeneron Pharmaceuticals REGN:US $ 1295.6M 167.5M
Ultragenyx Pharmaceutical RARE:US $ 124.76M 32.21M
United Therapeutics UTHR:US $ 22.15M 2.48M
Vertex Pharmaceuticals VRTX:US $ 806.45M 11.57M